XRCC1 and XPD polymorphisms and their relation to the clinical course in hepatocarcinoma patients

Guan,Qinghai; Chen,Zhiqiang; Chen,Qiangpu; Zhi,Xuting

doi:10.3892/ol.2017.6522

XRCC1 and XPD polymorphisms and their relation to the clinical course in hepatocarcinoma patients

Authors:
- Qinghai Guan
- Zhiqiang Chen
- Qiangpu Chen
- Xuting Zhi
View Affiliations

Affiliations: Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, Department of General Surgery, The Affiliated Hospital of Binzhou Medical College, Binzhou, Shandong 256603, P.R. China
Published online on: July 5, 2017 https://doi.org/10.3892/ol.2017.6522
Pages: 2783-2788
Copyright: © Guan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In this study genotyping of hepatocellular carcinoma (HCC) patients was conducted to detect polymorphisms on the X-ray repair cross-complementing 1 (XRCC1) and xeroderma pigmentosum complementary group D (XPD) genes and analyze the relationship of their presence with the clinical features of the cancer. A total of 172 patients with HCC were selected in Qilu Hospital, Shandong University, from January 2010 to September 2011. All patients underwent resection of HCC and no tumor metastases were found. Peripheral venous blood samples (3-5 ml) were collected from the patients to extract genomic DNA. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and gene sequencing. During the five-year follow-up, the survival of patients with various genotypes of XRCC1 and XPD genes were observed and compared. Logistic regression analysis was used to analyze the association between single nucleotide polymorphisms of XRCC1 and XPD genes and the prognosis of patients with HCC. χ2 tests showed that XRCC1-194, XRCC1-280 and XPD-312 gene polymorphisms were significantly correlated with the number, location and diameter of the tumors (p<0.05). No significant difference was found in the survival curve of patients presenting different genotypes of the XRCC1-194 locus (p>0.05). Nevertheless, a significant difference was found in the survival curve of patients with AA and GG genotypes of the XRCC1-280 locus and in the patients with AA, GA and GG genotypes of the XPD-312 locus (p<0.05). Logistic regression analysis showed that the XRCC1-194 genotype was not an independent risk factor for HCC mortality risk (p>0.05), but XRCC1-280 (OR=1.815, p<0.01) and XPD-312 (OR=1.815, p<0.01) genotypes were independent risk factors for a poor prognosis. Taken together our results point to polymorphisms in XRCC1 and XPD genes as being related to the clinical characteristics of HCC, making them suitable prognostic markers of HCC.

View Figures

View References

1	Bruix J, Gores GJ and Mazzaferro V: Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut. 63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
2	Lee SS, Shin HS, Kim HJ, Lee SJ, Lee HS, Hyun KH, Kim YH, Kwon BW, Han JH, Choi H, et al: Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: A single-center experience. Korean J Hepatol. 18:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
3	Kew MC: Hepatocellular carcinoma: Epidemiology and risk factors. J Hepatocell Carcinoma. 1:115–125. 2014. View Article : Google Scholar : PubMed/NCBI
4	Seguí N, Mina LB, Lázaro C, Sanz-Pamplona R, Pons T, Navarro M, Bellido F, López-Doriga A, Valdés-Mas R, Pineda M, et al: Germline mutations in FAN1 cause hereditary colorectal cancer by impairing DNA repair. Gastroenterology. 149:563–566. 2015. View Article : Google Scholar : PubMed/NCBI
5	Patrono C, Sterpone S, Testa A, Verna L, Palma V, Gentile P and Cozzi R: Polymorphisms in X-ray repair cross-complementing group 1 gene: Haplotypes, breast cancer risk and individual radiosensitivity. Open Med J. 2:25–30. 2015. View Article : Google Scholar
6	Tamura D, DiGiovanna JJ, Khan SG and Kraemer KH: Living with xeroderma pigmentosum: Comprehensive photoprotection for highly photosensitive patients. Photodermatol Photoimmunol Photomed. 30:146–152. 2014. View Article : Google Scholar : PubMed/NCBI
7	Wang YX, De Baere T, Idee JM and Ballet S: Transcatheter embolization therapy in liver cancer: An update of clinical evidences. Chin J Cancer Res. 27:96–121. 2015.PubMed/NCBI
8	Hung HH, Chao Y, Chiou YY, Li CP, Lee RC, Huo TI, Huang YH, Chau GY, Su CW, Yeh YC, et al: A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6. Medicine (Baltimore). 93:e3482014. View Article : Google Scholar : PubMed/NCBI
9	Liu F, Wang J, Chang H, Lu J and Li H: Relevance between HLA-DP gene rs2281388 polymorphism and hepatocellular carcinoma risk. Int J Clin Exp Pathol. 8:7431–7435. 2015.PubMed/NCBI
10	Huang X, Zeng Y, Xing X, Zeng J, Gao Y, Cai Z, Xu B, Liu X, Huang A and Liu J: Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection. Proteome Sci. 12:222014. View Article : Google Scholar : PubMed/NCBI
11	Petta S, Miele L, Bugianesi E, Cammà C, Rosso C, Boccia S, Cabibi D, Di Marco V, Grimaudo S, Grieco A, et al: Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease. PLoS One. 9:e875232014. View Article : Google Scholar : PubMed/NCBI
12	Akhdar H, El Shamieh S, Musso O, Désert R, Joumaa W, Guyader D, Aninat C, Corlu A and Morel F: The rs3957357C>T SNP in GSTA1 is associated with a higher risk of occurrence of hepatocellular carcinoma in european individuals. PLoS One. 11:e01675432016. View Article : Google Scholar : PubMed/NCBI
13	Duxin JP and Walter JC: What is the DNA repair defect underlying Fanconi anemia? Curr Opin Cell Biol. 37:49–60. 2015. View Article : Google Scholar : PubMed/NCBI
14	Bharati R, Jenkins MA, Lindor NM, Le Marchand L, Gallinger S, Haile RW, Newcomb PA, Hopper JL and Win AK: Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer? Gynecol Oncol. 133:287–292. 2014. View Article : Google Scholar : PubMed/NCBI
15	Caldecott KW: DNA single-strand break repair. Exp Cell Res. 329:2–8. 2014. View Article : Google Scholar : PubMed/NCBI
16	Fahmideh M Adel, Schwartzbaum J, Frumento P and Feychting M: Association between DNA repair gene polymorphisms and risk of glioma: A systematic review and meta-analysis. Neuro Oncol. 16:807–814. 2014. View Article : Google Scholar : PubMed/NCBI
17	Wang JY and Cai Y: X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: An updated meta-analysis. Tumour Biol. 35:411–418. 2014. View Article : Google Scholar : PubMed/NCBI
18	Li Y, Ma QH, Huang ZY, Li SW, Liu F and Tan S: P0163 X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: A systematic review and meta-analysis. Eur J Cancer. 50:e552014. View Article : Google Scholar
19	Liu J, Fang H, Chi Z, Wu Z, Wei D, Mo D, Niu K, Balajee AS, Hei TK, Nie L, et al: XPD localizes in mitochondria and protects the mitochondrial genome from oxidative DNA damage. Nucleic Acids Res. 43:5476–5488. 2015. View Article : Google Scholar : PubMed/NCBI
20	Bănescu C, Trifa AP, Demian S, Lazar E Benedek, Dima D, Duicu C and Dobreanu M: Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia. BioMed Res Int. 2014:2137902014. View Article : Google Scholar : PubMed/NCBI
21	Li P, Wang YD, Cheng J, Chen JC and Ha MW: Association between polymorphisms of BAG-1 and XPD and chemotherapy sensitivity in advanced non-small-cell lung cancer patients treated with vinorelbine combined cisplatin regimen. Tumour Biol. 36:9465–9473. 2015. View Article : Google Scholar : PubMed/NCBI